Ferreira JP, Verma S, Fitchett D, Ofstad AP, Lauer S, Zwiener I, George J, Wanner C, Zinman B, Inzucchi SE
Understanding Medical Weight Loss Semaglutide Semaglutide belongs to a class of medications known as GLP-1 receptor agonists
These effects result from the medication's action on gastric motility and can significantly impact nutritional intake and quality of life
If youd like to explore whether semaglutide is right for your weight-loss goals, we invite you to contact us at one of our greater San Antonio, Texas, locations
A 2023 meta-analysis of 11 randomized controlled trials found that GLP-1 monotherapy achieved average body weight reductions of 1222%, with improvements in blood glucose control, blood pressure, and cholesterol profiles as secondary benefits